Recent clinical studies surrounding the medication Retatrutide , specifically the 120mg formulation referred to as ZPHC, suggest a impressive benefit on weight decrease and related health factors. Experts believe that this dual agonist , affecting both GLP-1 and GIP receptors , could offer a noteworthy improvement in the treatment of excess weight